No CrossRef data available.
Article contents
Supplementation of diet with Astaxanthin and DHA prevents gestational and lactational undernourishment-induced metabolic derangements in dams: a metabolomic approach
Published online by Cambridge University Press: 28 November 2024
Abstract
Nutrition is the critical nongenetic factor that has a major influence on the health status of an organism. The nutritional status of the mother during gestation and lactation plays a vital role in defining the offspring’s health. Undernutrition during these critical periods may induce chronic metabolic disorders like obesity and cardiovascular diseases in mothers as well as in offspring. The present study aims to evaluate the impact of undernutrition during gestational and lactational periods on the plasma metabolic profile of dams. Additionally, we investigated the potential synergistic mitigating effects of astaxanthin and docosahexaenoic acid (DHA) on dysregulated plasma metabolic profiles. Evaluation of plasma lipid profile revealed that undernourishment resulted in elevated levels of total cholesterol, triglycerides, low density and very low-density lipoproteins in dams. Liquid chromatography-tandem mass spectrometry (LC–MS/MS) based untargeted metabolomics illustrated that pathways related to lipid metabolism, such as cholesterol metabolism, steroid biosynthesis and metabolism of amine-derived hormones, were dysregulated by undernourishment. Additionally, pathway enrichment analysis predicted that there is a high incidence of development of desmosterolosis, hypercholesterolaemia, lysosomal acid lipase deficiency and Smith–Lemli–Opitz syndrome in the offspring, reflecting predisposition in mothers. However, synergistic supplementation of astaxanthin and DHA ameliorated these adverse effects by regulating a separate set of metabolic pathways associated with lipid metabolism. They included branched chain amino acid degradation such as valine, leucine and isoleucine, metabolism of alpha-linolenic acid, lipoic acid, lysine degradation, biosynthesis, elongation and degradation of fatty acids.
Keywords
- Type
- Original Article
- Information
- Copyright
- © Dmodara Gowda K M, 2024. Published by Cambridge University Press in association with The International Society for Developmental Origins of Health and Disease (DOHaD)
References
Young, MF, Ramakrishnan, U. Maternal undernutrition before and during pregnancy and offspring health and development. Ann Nutr Metab. 2020; 76, 41–53.CrossRefGoogle Scholar
Serbesa, ML, Iffa, M, Geleto, M. Factors associated with malnutrition among pregnant women and lactating mothers in Miesso Health Center, Ethiopia. Eur J Midwifery. 2019; 3, 13.CrossRefGoogle ScholarPubMed
Tilahun, AG, Fufa, DA, Taddesse, RD. Undernutrition and its associated factors among pregnant women at the public hospitals of Bench-Sheko and Kaffa zone, Southwest Ethiopia. Heliyon 2022; 8, e09380.CrossRefGoogle ScholarPubMed
United Nations Children’s Fund (UNICEF). Undernourished and Overlooked: A Global Nutrition Crisis in Adolescent Girls and Women. UNICEF Child Nutrition Report Series, 2022. UNICEF, New York, 2023. https://www.unicef.org/nutrition/maternal
Google Scholar
Visioli, F, Artaria, C. Astaxanthin in cardiovascular health and disease: mechanisms of action, therapeutic merits, and knowledge gaps. Food Funct. 2017; 8, 39–63.CrossRefGoogle ScholarPubMed
Ambati, R, Phang, S-M, Ravi, S, Aswathanarayana, R. Astaxanthin: sources, extraction, stability, biological activities and its commercial applications—A review. Mar Drugs. 2014; 12, 128–152.CrossRefGoogle ScholarPubMed
Fassett, RG, Coombes, JS. Astaxanthin, oxidative stress, inflammation and cardiovascular disease. Future Cardiol. 2009; 5, 333–342.CrossRefGoogle ScholarPubMed
Fassett, RG, Coombes, JS. Astaxanthin in cardiovascular health and disease. Molecules 2012; 17, 2030–2048.CrossRefGoogle ScholarPubMed
Saini, RK, Keum, Y-S. Omega-3 and omega-6 polyunsaturated fatty acids: dietary sources, metabolism, and significance — A review. Life Sci. 2018; 203, 255–267.CrossRefGoogle ScholarPubMed
Horrocks, LA, Yeo, YK. Health benefits of Docosahexaenoic Acid (DHA). Pharmacol Res. 1999; 40, 211–225.CrossRefGoogle ScholarPubMed
Couet, C, Delarue, J, Ritz, P, Antoine, JM, Lamisse, F. Effect of dietary fish oil on body fat mass and basal fat oxidation in healthy adults. Int J Obes Relat Metab Disord J Int Assoc Study Obes. 1997; 21, 637–643.CrossRefGoogle ScholarPubMed
Hong, L, Zahradka, P, Cordero-Monroy, L, Wright, B, Taylor, CG. Dietary Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA) operate by different mechanisms to modulate hepatic steatosis and Hyperinsulemia in fa/fa Zucker rats. Nutrients 2019; 11, 917.CrossRefGoogle ScholarPubMed
Backes, J, Anzalone, D, Hilleman, D, Catini, J. The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia. Lipids Health Dis. 2016; 15, 118.CrossRefGoogle ScholarPubMed
Bhat Agni, M, Hegde, PS, Ullal, H, Damodara Gowda, KM. Nutritional efficacy of Astaxanthin in modulating Orexin peptides and fatty acid level during adult life of rats exposed to perinatal undernutrition stress. Nutr Neurosci. 2023; 26, 1045–1057.CrossRefGoogle ScholarPubMed
Gazquez, A, Larqué, E. Towards an optimized fetal DHA accretion: differences on maternal DHA supplementation using Phospholipids vs. Triglycerides during pregnancy in different models. Nutrients 2021; 13, 511.CrossRefGoogle ScholarPubMed
Agni, MB, Hegde, PS, Rai, P, Sadananda, M. Astaxanthin and DHA supplementation modulates the maternal undernutrition-induced impairment of cognitive behavior and synaptic plasticity in adult life of offspring’s-exploring the molecular mechanism. Mol. Neurobiol. 2024;4, 1–21.Google Scholar
Yoon, H, Shaw, JL, Haigis, MC, Greka, A. Lipid metabolism in sickness and in health: emerging regulators of lipotoxicity. Mol Cell. 2021; 81, 3708–3730.CrossRefGoogle ScholarPubMed
Barros, MP, Marin, DP, Bolin, AP, et al. Combined astaxanthin and fish oil supplementation improves Glutathione-based redox balance in rat plasma and Neutrophils. Chem Biol Interact. 2012; 197, 58–67.CrossRefGoogle ScholarPubMed
Guesnet, P, Pugo-Gunsam, P, Maurage, C, et al. Blood lipid concentrations of Docosahexaenoic and Arachidonic Acids at birth determine their relative postnatal changes in term infants fed breast milk or formula2. Am J Clin Nutr. 1999; 70, 292–298.CrossRefGoogle ScholarPubMed
Lauritzen, L, Brambilla, P,Mazzocchi, A, et al. DHA effects in brain development and function. Nutrients 2016; 8, 6.CrossRefGoogle Scholar
Innis, SM. Fatty acids and early human development. Early Hum Dev. 2007; 83, 761–766.CrossRefGoogle ScholarPubMed
Emmett, PM, Jones, LR, Golding, J. Pregnancy diet and associated outcomes in the Avon longitudinal study of parents and children. Nutr Rev. 2015; 73, 154–174.CrossRefGoogle ScholarPubMed
De Giuseppe, R, Roggi, C, Cena, H. n-3 LC-PUFA supplementation: effects on infant and maternal outcomes. Eur J Nutr. 2014; 53,1147–1154.Google ScholarPubMed
Brendler, T, Williamson, EM Astaxanthin: How much is too much? A safety review. Phytotherapy Research. 2019; 12, 3090–3111.CrossRefGoogle Scholar
Neto, Jão, Jantsch, J, de Oliveira, S, et al. DHA/EPA supplementation decreases anxiety-like behaviour, but it does not ameliorate metabolic profile in obese male rats. Br J Nutr. 2022; 128, 964–974.CrossRefGoogle Scholar
Ranade, AV, Hegde, PS, Bhat, MA, et al. Astaxanthin and DHA supplementation ameliorates the proteomic profile of perinatal undernutrition-induced adipose tissue dysfunction in adult life. Sci Rep. 2023; 13(1), 12312.CrossRefGoogle ScholarPubMed
Lau, SK, Lam, CW, Curreem, SO,
et al. Identification of specific metabolites in culture supernatant of Mycobacterium tuberculosis using metabolomics: exploration of potential biomarkers. Emerg Microbes Infect. 2015;4(1), e6.CrossRefGoogle ScholarPubMed
Mate, A, Reyes-Goya, C, Santana-Garrido, Á., Sobrevia, L, Vázquez, CM. Impact of maternal nutrition in viral infections during pregnancy. Biochim Biophys Acta Mol Basis Dis. 2021; 1867, 166231.CrossRefGoogle ScholarPubMed
Nsereko, E, Uwase, A, Mukabutera, A, et al. Maternal genitourinary infections and poor nutritional status increase risk of preterm birth in Gasabo district, Rwanda: a prospective, longitudinal, cohort study. BMC Pregnancy Childbirth 2020; 20, 345.CrossRefGoogle ScholarPubMed
Bays, HE, Kirkpatrick, C, Maki, KC, et al. Obesity, dyslipidemia, and cardiovascular disease: a joint expert review from the obesity medicine association and the national lipid association 2024. Obes Pillars. 2024; 10, 100108.CrossRefGoogle ScholarPubMed
Balla, T. Phosphoinositides: tiny lipids with giant impact on cell regulation. Physiol Rev. 2013; 93, 1019–1137.CrossRefGoogle ScholarPubMed
Oudit, GY, Penninger, JM. Cardiac regulation by Phosphoinositide 3-kinases and PTEN. Cardiovasc Res. 2009; 82, 250–260.CrossRefGoogle ScholarPubMed
Li, L, Wang, P, Jiao, X, et al. Fatty acid esters of hydroxy fatty acids: a potential treatment for obesity-related diseases. Obes Rev. 2024; 25, e13735.CrossRefGoogle ScholarPubMed
Kelly, RS, Croteau-Chonka, DC, Dahlin, A, et al. Integration of metabolomic and transcriptomic networks in pregnant women reveals biological pathways and predictive signatures associated with preeclampsia. Metabolomics Off J Metabolomic Soc. 2017; 13, 7.Google ScholarPubMed
Mills, HL, Patel, N, White, SL, et al. The effect of a lifestyle intervention in obese pregnant women on gestational metabolic profiles: findings from the UK Pregnancies Better Eating and Activity Trial (UPBEAT) randomised controlled trial. BMC Med. 2019; 17, 15.CrossRefGoogle ScholarPubMed
Li, J, Papadopoulos, V, Vihma, V. Steroid biosynthesis in adipose tissue. Steroids 2015; 103, 89–104.CrossRefGoogle ScholarPubMed
Akalestou, E, Genser, L, Rutter, GA. Glucocorticoid metabolism in obesity and following weight loss. Front Endocrinol. 2020;11:59.CrossRefGoogle ScholarPubMed
Rohanizadegan, M, Sacharow, S. Desmosterolosis presenting with multiple congenital anomalies. Eur J Med Genet. 2018;61(3), 152–156.CrossRefGoogle ScholarPubMed
Nowaczyk, MJ, Wassif, CA. Smith-Lemli-Opitz syndrome. 1998 Nov 13 [Updated 2020 Jan 30]. In: (eds. Adam MP, Feldman J, Mirzaa GM, et al.) GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024.Google Scholar
Hoffman, EP, Barr, ML, Giovanni, MA, et al. Lysosomal acid lipase deficiency. 2015 Jul 30 [Updated 2016 Sep 1]. In: (eds. Adam MP, Feldman J, Mirzaa GM, et al.). GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024.Google Scholar
Zhao, X, Han, Q, Liu, Y, et al. The relationship between branched-chain amino acid related metabolomic signature and Insulin resistance: a systematic review. J Diabetes Res. 2016; 2016, 2794591.CrossRefGoogle ScholarPubMed
Yu, D, Richardson, NE, Green, CL, et al. The adverse metabolic effects of branched-chain amino acids are mediated by Isoleucine and Valine. Cell Metab. 2021; 33, 905–922.e6.CrossRefGoogle ScholarPubMed
Wang, Q, Wang, X. The effects of a low Linoleic Acid/α-Linolenic Acid ratio on lipid metabolism and endogenous fatty acid distribution in Obese mice. Int J Mol Sci. 2023; 24, 12117.CrossRefGoogle ScholarPubMed
Kasaoka, S, Tsuboyama-Kasaoka, N, Kawahara, Y, et al. Histidine supplementation suppresses food intake and fat accumulation in rats. Nutr. 2004; 20, 991–996.CrossRefGoogle ScholarPubMed
Ma, Q, Zhou, X, Hu, L, Chen, J, Zhu, J, Shan, A. Leucine and Isoleucine have similar effects on reducing lipid accumulation, improving Insulin sensitivity and increasing the browning of WAT in high-fat diet-induced Obese mice. Food Funct. 2020; 11, 2279–2290.CrossRefGoogle ScholarPubMed
Shipelin, VA, Trusov, NV, Apryatin, SA, et al. Effects of Tyrosine and Tryptophan in rats with diet-induced obesity. Int J Mol Sci. 2021; 22, 2429.CrossRefGoogle ScholarPubMed
Xiao, CW, Wood, C, Bertinato, J. Dietary supplementation with L-lysine affects body weight and blood hematological and biochemical parameters in rats. Mol Biol Rep. 2019; 46, 433–442.CrossRefGoogle ScholarPubMed
Lee, LM-Y, Lin, ZQ, Zheng, LX, et al. Lysine deprivation suppresses adipogenesis in 3T3-L1 cells: a transcriptome analysis. Int J Mol Sci. 2023; 24, 9402.CrossRefGoogle ScholarPubMed
Namazi, N, Larijani, B, Azadbakht, L. Alpha-Lipoic acid supplement in obesity treatment: a systematic review and meta-analysis of clinical trials. Clin Nutr Edinb Scotl. 2018; 37, 419–428.Google ScholarPubMed
Koh, EH, Lee, WJ, Lee, SA, et al. Effects of alpha-Lipoic Acid on body weight in obese subjects. Am J Med. 2011; 124, 85.e1–85.e8.CrossRefGoogle ScholarPubMed
Jia, Y, Wu, C, Kim, J, et al. Astaxanthin reduces Hepatic lipid accumulations in high-fat-fed C57BL/6J mice via activation of Peroxisome Proliferator-Activated Receptor (PPAR) alpha and inhibition of PPAR gamma and Akt. J Nutr Biochem. 2016; 28, 9–18.CrossRefGoogle ScholarPubMed
Lin, HC, Lii, CK, Lin, AH, et al. Docosahexaenoic acid inhibits TNFα-induced ICAM-1 expression by activating PPARα and autophagy in human endothelial cells. Food Chem Toxicol. 2019; 134, 110811.CrossRefGoogle ScholarPubMed
Deng, X, Dong, Q, Bridges, D, et al. Docosahexaenoic acid inhibits proteolytic processing of sterol regulatory element-binding protein-1c (SREBP-1c) via activation of AMP-activated kinase. Biochim Biophys Acta BBA - Mol Cell Biol Lipids. 2015; 1851(12), 1521–1529.Google ScholarPubMed
Hegde et al. supplementary material
Hegde et al. supplementary material
File
1.3 MB